BNT162b2 boosted neutralizing antibody titers after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination

被引：0

作者：

Hammerschmidt, S. I. ^{[1
]}

Barros-Martins, J. ^{[1
]}

Cossmann, A. ^{[2
]}

Ramos, G. Morillas ^{[2
]}

Stankow, M. V. ^{[2
]}

Odak, I. ^{[1
]}

Dopfer-Jablonka, A. ^{[2
,3
]}

Hetzel, L. ^{[2
]}

Koehler, M. ^{[1
]}

Patzer, G. ^{[1
]}

Binz, C. ^{[1
]}

Ritter, C. ^{[1
]}

Friedrichsen, M. ^{[1
]}

Schultze-Florey, C. ^{[1
,4
]}

Ravens, I. ^{[1
]}

Willenzon, S. ^{[1
]}

Bubke, A. ^{[1
]}

Ristenpart, J. ^{[1
]}

Janssen, A. ^{[1
]}

Ssebyatika, G. ^{[5
]}

Kraehling, V. ^{[6
,7
]}

Bernhardt, G. ^{[1
]}

Hoffmann, M. ^{[8
,9
]}

Poehlmann, S. ^{[8
,9
]}

Krey, T. ^{[5
,10
]}

Bosnjak, B. ^{[1
]}

Foester, R. ^{[1
,3
,11
]}

Behrens, G. M. N. ^{[2
,3
,12
]}

机构：

[1] Hannover Med Sch, Inst Immunol, Hannover, Germany

[2] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany

[3] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany

[4] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[5] Univ Lubeck, Inst Biochem, Lubeck, Germany

[6] Philipps Univ Marburg, Inst Virol, Marburg, Germany

[7] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany

[8] German Primate Ctr, Infect Biol Unit, Gottingen, Germany

[9] Georg August Univ Gottingen, Fac Biol & Psychol, Hannover, Germany

[10] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig & Partner Site, Hamburg, Germany

[11] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany

[12] Ctr Individualized Infect Med CiiM, Hannover, Germany

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P 005

引用

页码：154 / 155

页数：2

共 50 条

[1] Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Reiter, Rieke
Von Blanckenburg, Pia
Mutters, Reinier
Thiemer, Julia
Gessner, Reinhard
Seifart, Ulf
VACCINES, 2022, 10 (05)
[2] BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Behrens, Georg M. N.
Barros-Martins, Joana
Cossmann, Anne
Ramos, Gema Morillas
Stankov, Metodi, V
Odak, Ivan
Dopfer-Jablonka, Alexandra
Hetzel, Laura
Koehler, Miriam
Patzer, Gwendolyn
Binz, Christoph
Ritter, Christiane
Friedrichsen, Michaela
Schultze-Florey, Christian
Ravens, Inga
Willenzon, Stefanie
Bubke, Anja
Ristenpart, Jasmin
Janssen, Anika
Ssebyatika, George
Kraehling, Verena
Bernhardt, Guenter
Hoffmann, Markus
Poehlmann, Stefan
Krey, Thomas
Bosnjak, Berislav
Hammerschmidt, Swantje, I
Foerster, Reinhold
NATURE COMMUNICATIONS, 2022, 13 (01)
[3] BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Georg M. N. Behrens
Joana Barros-Martins
Anne Cossmann
Gema Morillas Ramos
Metodi V. Stankov
Ivan Odak
Alexandra Dopfer-Jablonka
Laura Hetzel
Miriam Köhler
Gwendolyn Patzer
Christoph Binz
Christiane Ritter
Michaela Friedrichsen
Christian Schultze-Florey
Inga Ravens
Stefanie Willenzon
Anja Bubke
Jasmin Ristenpart
Anika Janssen
George Ssebyatika
Verena Krähling
Günter Bernhardt
Markus Hoffmann
Stefan Pöhlmann
Thomas Krey
Berislav Bošnjak
Swantje I. Hammerschmidt
Reinhold Förster
Nature Communications, 13
[4] Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination
Bauswein, Markus
Peterhoff, David
Plentz, Annelie
Hiergeist, Andreas
Wagner, Ralf
Gessner, Andre
Salzberger, Bernd
Schmidt, Barbara
Bauernfeind, Stilla
ISCIENCE, 2022, 25 (02)
[5] Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
Barocci, Simone
Orlandi, Chiara
Diotallevi, Aurora
Buffi, Gloria
Ceccarelli, Marcello
Vandini, Daniela
Carlotti, Eugenio
Galluzzi, Luca
Rocchi, Marco Bruno Luigi
Magnani, Mauro
Casabianca, Anna
VACCINES, 2022, 10 (04)
[6] Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)
Tran, A. P.
Tassone, D.
Nossent, J. C.
Ding, N. S.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I403 - I404
[7] Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
Tenbusch, Matthias
Schumacher, Sofie
Vogel, Emanuel
Priller, Alina
Held, Juergen
Steininger, Philipp
Beileke, Stephanie
Irrgang, Pascal
Brockhoff, Ronja
Salmanton-Garcia, Jon
Tinnefeld, Kathrin
Mijocevic, Hrvoje
Schober, Kilian
Bogdan, Christian
Yazici, Sarah
Knolle, Percy
Cornely, Oliver A.
Ueberla, Klaus
Protzer, Ulrike
LANCET INFECTIOUS DISEASES, 2021, 21 (09): : 1212 - 1213
[8] Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)
Tran, A. P.
Tassone, D.
Nossent, J. C.
Ding, N. S.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I403 - I404
[9] Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
Bruno Pozzetto
Vincent Legros
Sophia Djebali
Véronique Barateau
Nicolas Guibert
Marine Villard
Loïc Peyrot
Omran Allatif
Jean-Baptiste Fassier
Amélie Massardier-Pilonchéry
Karen Brengel-Pesce
Melyssa Yaugel-Novoa
Solène Denolly
Bertrand Boson
Thomas Bourlet
Antonin Bal
Martine Valette
Thibault Andrieu
Bruno Lina
François-Loïc Cosset
Stéphane Paul
Thierry Defrance
Jacqueline Marvel
Thierry Walzer
Sophie Trouillet-Assant
Nature, 2021, 600 : 701 - 706
[10] Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
Zapata-Cardona, Maria, I
Florez-Alvarez, Lizdany
Lopera, Tulio J.
Chvatal-Medina, Mateo
Zapata-Builes, Wildeman
Diaz, Francisco J.
Aguilar-Jimenez, Wbeimar
Taborda, Natalia
Hernandez, Juan C.
Rugeles, Maria T.
FRONTIERS IN IMMUNOLOGY, 2022, 13

← 1 2 3 4 5 →